{"result": {"id": "chatcmpl-880", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "**Ranibizumab** is a medication used to treat eye diseases. It is an anti-VEGF agent used in anti-angiogenesis therapy for myopic CNV (choroidal neovascularization).  It is also known by its drug name and is used for the treatment of various conditions, including those related to vision problems. **Ranibizumab** is a drug used in both experimental settings and clinical treatments, designed to address eye diseases. It is effective in treating lesions classified as T1, T2, and T3. \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743288779, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 112, "prompt_tokens": 252, "total_tokens": 364, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"RANIBIZUMAB\"\nDescription List: [\"**Ranibizumab** is a medication used to treat eye diseases. It is an anti-VEGF agent used in anti-angiogenesis therapy for myopic CNV (choroidal neovascularization).  It is also known by its drug name and is used for the treatment of various conditions, including those related to vision problems. **Ranibizumab** is a drug used in both experimental settings and clinical treatments, designed to address eye diseases. \\n\", \"Drug used in T1, T2, and T3 lesions\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_0e9274b29de23d922ff9131c8f8c548f065301f61a7397435cb2386263a87adf_v2"}